Bryn Mawr Capital Management Inc’s Boston Scientific BSX Stock Holding History

Bryn Mawr Capital Management Inc’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-12,468	Closed	-$205K	–	49
2015 Q3	$205K	Buy	+12,468	New	+$213K	0.04%	422
2015 Q1	–	Sell	-24,855	Closed	-$329K	–	473
2014 Q4	$329K	Sell	24,855 -18,545	-43%	-$237K	0.04%	363
2014 Q3	$513K	Buy	43,400 +13,274	+44%	+$167K	0.05%	377
2014 Q2	$385K	Sell	30,126 -14,680	-33%	-$191K	0.04%	446
2014 Q1	$606K	Buy	44,806 +26,106	+140%	+$343K	0.05%	283
2013 Q4	$225K	Buy	+18,700	New	+$221K	0.01%	499

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bryn Mawr Capital Management Inc's BSX Position: Q4 2015 in Review

Bryn Mawr Capital Management Inc sold out of Boston Scientific (BSX) in Q4 2015, closing a stake of 12,468 shares — an estimated $205K sold.

Bryn Mawr Capital Management Inc first reported a position in BSX in Q4 2013 and held it in 6 quarters. The position peaked at $606K in Q1 2014. 502 funds tracked by Wall St. Rank hold BSX as of Q4 2015.

Bryn Mawr Capital Management Inc reported no remaining Boston Scientific position as of Q4 2015 after selling out during the quarter.
Bryn Mawr Capital Management Inc sold 12,468 Boston Scientific shares in Q4 2015, an estimated $205K.
Bryn Mawr Capital Management Inc first reported a position in Boston Scientific in Q4 2013 and held it in 6 quarters.
Bryn Mawr Capital Management Inc's Boston Scientific position peaked at $606K in Q1 2014.
502 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2015.

Based on Bryn Mawr Capital Management Inc's 13F filing for Q4 2015.